Erythromycin stearate is a salt form of erythromycin, formulated to enhance acid stability and absorption when taken orally. It is effective against a range of bacterial infections by inhibiting protein synthesis. It is grouped under the following drug class(es): Macrolides. Its therapeutic use is listed as anti-infectives. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Erythromycin Octadecanoate, Erythrocin Stearate, Bristamycin and Ethril. Its PubChem CID is 12559.
Erythromycin stearate
| CAS No | 643-22-1 |
|---|---|
| Molecular Formula | C37H67NO13.C18H36O2 |
| Molecular Weight | 1018.4 g/mol |
| Synonyms | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;octadecanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Erythromycin stearate is a salt form of erythromycin, formulated to enhance acid stability and absorption when taken orally. It is effective against a range of bacterial infections by inhibiting protein synthesis.
The listed CAS number is 643-22-1.
The listed molecular formula is C37H67NO13.C18H36O2.
The listed molecular weight is 1018.4 g/mol.
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;octadecanoic acid.
The source lists Erythromycin Octadecanoate, Erythrocin Stearate, Bristamycin and Ethril.